Mysimba
PopularOral Tablet — Non-GLP-1

Mysimba

Naltrexone/Bupropion

by Orexigen Therapeutics

Effective oral appetite control for patients who prefer tablets over injections

From$115.00$1.03/tablet
HIPAA-compliantUS-licensed physiciansDiscreet delivery
Mysimba medication

6.4%

Average placebo-adjusted weight loss

COR-I trial, Lancet 2010

55%

Patients achieved ≥5% weight loss

COR-I trial, Lancet 2010

28%

Patients achieved ≥10% weight loss

COR-I trial, Lancet 2010

56 weeks

Primary endpoint duration

COR-I trial, Lancet 2010

How It Works

Mechanism of Action

Mysimba combines two mechanisms: bupropion stimulates POMC (pro-opiomelanocortin) neurons in the hypothalamus to reduce appetite, while naltrexone blocks opioid receptors that would normally suppress POMC activity. Together, they create a sustained reduction in hunger and food cravings, particularly for high-reward foods.

Dosage Guide

Always follow your prescribing physician's specific instructions. The schedule below is a general guide.

1
Week 11 tablet in the morning

Initiation — one 8mg/90mg tablet each morning

2
Week 21 tablet AM + 1 tablet PM

Second dose added in the evening

3
Week 32 tablets AM + 1 tablet PM

Third daily tablet added to morning dose

4
Week 4+2 tablets AM + 2 tablets PM

Full maintenance dose — 32mg/360mg daily total

Key Benefits

Oral tablets — no injections required
Specifically targets food cravings and reward eating
Twice-daily dosing builds easily into routine
Helpful for patients with depression comorbid to obesity (bupropion component)
Widely available in the US and Europe

Side Effects

Common Side Effects

  • Nausea
  • Headache
  • Constipation
  • Dizziness
  • Insomnia
  • Dry mouth
  • Vomiting
  • Increased blood pressure

Rare but Serious

  • Seizures (rare but serious)
  • Suicidal thoughts (black box warning — monitor closely)
  • Liver damage (rare)
  • Hypersensitivity reactions

Seek immediate medical attention if you experience any serious adverse effects.

Frequently Asked Questions

Who Is This For?

  • Adults with BMI ≥30 kg/m²
  • Adults with BMI ≥27 kg/m² with weight-related comorbidities
  • Patients who prefer oral tablets to injections
  • Patients with emotional or compulsive eating patterns

Not Suitable For

  • Patients currently using opioids or in opioid withdrawal
  • Patients with uncontrolled hypertension
  • History of seizure disorder
  • Patients taking MAOIs
  • Pregnancy or breastfeeding
  • Patients with eating disorders (anorexia/bulimia)

Starting from

$115.00

$1.03/tablet

Reviewed by a licensed US physician

How It Works

1
Complete online consultation
2
Doctor reviews within 24 hrs
3
Prescription issued if approved
4
Discreet home delivery
HIPAA-compliant & secure
US-licensed prescribing physicians
NABP-accredited US pharmacies
SSL encrypted checkout

Ready to Start Your Mysimba Journey?

A licensed US physician will review your consultation, answer all your questions, and prescribe if you're eligible — all from the comfort of home.

No commitment · Reviewed within 24 hours · HIPAA-compliant

Talk with Us